• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDC
Click for more information
0.00% $6.60

MEDLAB CLINICAL LIMITED - News & Media

Market Cap $15.07M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.More

Articles & Videos

Medlab Clinical (ASX:MDC) gets green light to bring NanaBis into UK

Medlab Clinical (ASX:MDC) has received certification to import its NanaBis drug into the United Kingdom, helping pave the way to receiving market authority in the country.

25 Jan 2023 19:06 (AEDT)



(20min delay)
Last
$6.60 		Change
0.000(0.00%) 		Mkt cap ! $15.07M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
MDC (ASX) Chart

Top Stories

Carnarvon revs up for revised Dorado Development

The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.